Cytocore Inc Asset Turnover Ratio (CYOE), as of third quarter 2014, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Cytocore Inc  (CYOE)
 

Cytocore Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Cytocore Inc's asset turnover ratio, the ratio that measures the ability of Cytocore Inc's assets to generate revenue, sequentially decreased to 0.54 in the third quarter (Sep 30 2014), but it does not raise any concerns as Cytocore Inc continue to execute well, and the asset turnover ratio remains above the average.

Within sector 14 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2014 compared to the preceding quarter from 2326 to 2459.

Asset Turnover Ratio Definition



CYOE Asset Turnover Ratio (Sep 30 2014)
III. Quarter
(Jun 30 2014)
II. Quarter
(Mar 31 2014)
I. Quarter
(Dec 31 2013)
IV. Quarter
(Sep 30 2013)
III. Quarter
Y / Y Asset Change 46370.21 % 41146.3 % -84.95 % -91.98 % -84.23 %
Y / Y Revenue Change 55600 % 79275 % -72.73 % -42.86 % -91.8 %
Asset Turnover Ratio (TTM) 0.54 0.57 0.47 0.45 0.24
CYOE's Total Ranking # 2459 # 2326 # 2573 # 2648 # 3032
Seq. Asset Change -1.94 % 158992.86 % -33.33 % -55.32 % -12.96 %
Seq. Revenue Change -12.28 % 105733.33 % -25 % -20 % 25 %



Asset Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 15
Healthcare Sector # 207
Overall Market # 2459

Asset Turnover Ratio Statistics
High Average Low
0.76 0.52 0.24
(Mar 31 2013)   (Sep 30 2013)







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2014, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2014 Assets at quarter ending Sep 30 2014
Gilead Sciences Inc   0.75 $ 20,695.557  Millions$ 27,656.259  Millions
Bolt Biotherapeutics Inc   0.75 $ 63.220  Millions$ 84.570  Millions
Sonoma Pharmaceuticals Inc   0.75 $ 12.863  Millions$ 17.227  Millions
Pediatrix Medical Group Inc   0.75 $ 2,385.356  Millions$ 3,200.323  Millions
Edwards Lifesciences Corporation  0.74 $ 2,240.900  Millions$ 3,013.250  Millions
Biolife Solutions Inc   0.74 $ 8.980  Millions$ 12.099  Millions
Veru Inc   0.74 $ 24.491  Millions$ 33.182  Millions
Pacira Biosciences inc   0.73 $ 169.439  Millions$ 232.747  Millions
Cyteir Therapeutics Inc   0.72 $ 2,002.800  Millions$ 2,763.600  Millions
Axogen inc   0.72 $ 17.151  Millions$ 23.687  Millions
Charles River Laboratories International inc   0.72 $ 1,257.342  Millions$ 1,750.551  Millions
Biogen Inc   0.71 $ 9,028.549  Millions$ 12,678.902  Millions
Luminex Corporation  0.71 $ 224.033  Millions$ 315.724  Millions
Incyte Corporation  0.70 $ 484.593  Millions$ 690.191  Millions
Cutera Inc   0.70 $ 74.878  Millions$ 107.161  Millions
Becton Dickinson And Company  0.69 $ 8,446.000  Millions$ 12,276.500  Millions
Atricure Inc   0.68 $ 99.923  Millions$ 145.894  Millions
Conmed Corporation  0.68 $ 748.494  Millions$ 1,095.136  Millions
Rti Surgical Holdings Inc   0.68 $ 252.443  Millions$ 370.510  Millions
Retractable Technologies Inc  0.68 $ 31.348  Millions$ 46.031  Millions
Abbvie Inc   0.68 $ 19,619.000  Millions$ 28,838.500  Millions
Resmed Inc   0.67 $ 1,577.710  Millions$ 2,345.142  Millions
Merit Medical Systems Inc  0.67 $ 496.925  Millions$ 740.180  Millions
Baxter International Inc   0.65 $ 16,734.000  Millions$ 25,580.500  Millions
Livewire Ergogenics Inc.  0.65 $ 0.237  Millions$ 0.365  Millions
Bard C R Inc  0.64 $ 3,247.700  Millions$ 5,037.750  Millions
Immucell Corporation  0.64 $ 6.951  Millions$ 10.896  Millions
Enovis Corp  0.64 $ 4,589.498  Millions$ 7,202.806  Millions
Bio rad Laboratories Inc   0.64 $ 2,179.420  Millions$ 3,420.986  Millions
Haemonetics Corporation  0.63 $ 935.279  Millions$ 1,488.337  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.